Targeted Therapy of Hepatocellular Carcinoma Using Gemcitabine-Incorporated GPC3 Aptamer

• Asıl Yazarlar: Jun Young Park (Yazar), Ju Ri Chae (Yazar), Ye Lim Cho (Yazar), Youndong Kim (Yazar), Dasom Lee (Yazar), Jeong Kyun Lee (Yazar), Won Jun Kang (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2020-10-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Hepatocellular carcinoma (HCC) is the most common malignancy of the liver, which can progress rapidly and has a poor prognosis. Glypican-3 (GPC3) has been proposed to be an important diagnostic biomarker and therapeutic target for HCC. Aptamers have emerged as promising drug delivery vehicles becaus...